Thromb Haemost 1988; 60(01): 122
DOI: 10.1055/s-0038-1647648
Letter to the Editor
Schattauer GmbH Stuttgart

A Study of Proteins C and S in Patients with Prostatic Disease

Benjamin Esparaz
Northwestern University Medical School, 345 East Superior Street Chicago, Illinois 60611, USA
,
David Green
Northwestern University Medical School, 345 East Superior Street Chicago, Illinois 60611, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 23. Februar 1988

Accepted 10. März 1988

Publikationsdatum:
30. Juni 2018 (online)

 
  • References

  • 1 Rapaport SI, Chapman CG. Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. Am J Med 1959; 27: 144-153
  • 2 Pineo GF, Brain MC, Gallus AS. Tumors, mucus production and hypercoagulability. Ann NYA. cad Sci 1974; 230: 262-270
  • 3 Bick RL. Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management. Semin Thromb Haemostas 1978; 5: 1-6
  • 4 Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186
  • 5 Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood 1987; 69: 692-694
  • 6 Green D, Ganger DR, Blei AT. Protein C deficiency in splanchnic venous thrombosis. Am J Med 1987; 82: 1171-1174